The mammalian gut is home to hundreds of bacterial species that contribute to food digestion and, in some cases, inflammatory gut diseases. Probiotics, beneficial bacterial species, can enhance gut health by keeping the resident bacteria in check. Now, a team of researchers at the RIKEN Innovation Center in Wako, including Mitsuharu Matsumoto, report that administration of the probiotic bacterial strain Bifidobacterium animalis subspecies lactis LKM512 to mice can lengthen their lifespan1.
Figure 1: Compared with untreated aging mice (left), LKM512 maintains a healthy gut lining in treated aging mice (right) (scale bar, 500 ìm).
Copyright : 2011 Mitsuharu Matsumoto et al.
Matsumoto and colleagues previously showed that LKM512 could reduce inflammatory markers in elderly humans and modify the makeup of intestinal bacteria2, but the effects of it on lifespan still required investigation. After starting 10-month-old mice on a diet including LKM512 for 11 months, the researchers found that LKM512-treated mice lived longer, had fewer skin lesions, and had better hair quality than untreated mice.
Analyses of the gut of these mice revealed elevated gene expression in some bacterial species compared with control mice, indicating that LKM512 may improve gut health indirectly by regulating the levels of other bacterial species. The LKM512 treatment also prevented some age-related changes in bacterial composition of the gut, suggesting that the probiotic treatment protects the gut from developing characteristics associated with aging.
Acting as a barrier between the bacteria and food within the gut and the rest of the human body is an important role of the gut lining. Breakdown of this lining can cause infectious or inflammatory diseases. The researchers found that the gut of LKM512-treated mice served as a stronger barrier than the gut of control mice. LKM512 seemed to perform this function by increasing the expression of various proteins that maintain the tight connection between gut epithelial cells.
Polyamines are chemicals that reduce inflammation, and their levels decrease as an individual ages. Matsumoto and colleagues observed increases in intestinal polyamine levels in LKM512-treated mice, which may be caused by the greater numbers of bacteria promoted by LKM512. The increase in polyamines caused by LKM512 appeared to reduce inflammation in the body of the mice, as inflammatory markers in the blood and urine were lower in LKM512-treated mice compared with controls. In aged mice treated with LKM512, inflammatory marker levels were similar to those observed in younger mice, indicating that adults can benefit from probiotics.
“In future work, we hope to clarify the effectiveness of LKM512 in humans,” explains Matsumoto. If the findings extend to humans, inclusion of LKM512 into the human diet could enhance overall health and increase the human lifespan.
The corresponding author for this highlight is based at the Benno Laboratory, RIKEN Research Cluster for Innovation
Closing the carbon loop
08.12.2016 | University of Pittsburgh
Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences